Unigene's Proprietary Peptelligence™ Platform Selected By Stealth Peptides For An Oral Phase 1 Clinical Study
nvestor Contact:Unigene Laboratories, Inc.
Jenene Thomas VP, Investor Relations and Business Administration 973-265-1107
Media Contact:Tiberend Strategic Advisors, Inc.
Jason Rando /
SOURCE Unigene Laboratories, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts